CAR Antigen | Institute | Sample | Participants Effective Number | Year of Publishing | Ref. | |
Number (M/F) | Age | |||||
CD19 2nd CD28 | National Cancer Institute | 15d (8/7) | 51.67 ± 11.22 | 15d | 2014 | [114] |
CD19 2nd 4-1BB | University of Pennsylvania | 14 (12/2) | 66.90 ± 8.10 | 14 | 2015 | [1] [136] |
CD19 2nd CD28 | National Cancer Institute | 20 (11/9) | 50.93 ± 12.86 | 20e | 2016 | [136] |
CD19 3rd CD28/4-1BB | Fred Hutchinson Cancer Research Center | 24f | 59.54 ± 7.87 | 24 | 2017 | [137] |